InvestorsHub Logo
Followers 22
Posts 1671
Boards Moderated 0
Alias Born 12/12/2006

Re: None

Monday, 12/17/2018 7:17:45 PM

Monday, December 17, 2018 7:17:45 PM

Post# of 8400
Dew,

From Fosun website: “As of the date hereof, there are no products containing DaxibotulinumtoxinA (a botulinum toxin type A) marketed within China (excluding Hong Kong, Macao and Taiwan, the same below)”

Does above mean AGN are not marketing Botox in China yet ? Hard to imagine China is a nascent market given growing appetite for anything consumer related.

Anyway the fact Fosun went with RVNC tells me they view RT002 - long acting toxin as a well differentiated product enough to induce significant uptake & product success.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News